Cited by 201Dermatology and Skin DiseasesContact Dermatitis and AllergiesAdvancements in Transdermal Drug Delivery

Skin barrier defects in atopic dermatitis

Open access
Agrawal, Rachana, Woodfolk, Judith A.·2014·Current Allergy and Asthma Reports

Abstract

Atopic dermatitis (AD) is a chronic inflammatory skin condition with complex etiology that is dependent upon interactions between the host and the environment. Acute skin lesions exhibit the features of a Th2-driven inflammatory disorder, and many patients are highly atopic. The skin barrier plays key roles in immune surveillance and homeostasis, and in preventing penetration of microbial products and allergens. Defects that compromise the structural integrity or else the immune function of the skin barrier play a pivotal role in the pathogenesis of AD. This article provides an overview of the array of molecular building blocks that are essential to maintaining healthy skin. The basis for structural defects in the skin is discussed in relation to AD, with an emphasis on filaggrin and its genetic underpinnings. Aspects of innate immunity, including the role of antimicrobial peptides and proteases, are also discussed.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s11882-014-0433-9

Cites

118 of 118 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • One of the main genetic factors associated with AD is the mutation in the FLG gene, which produces function impairment leading to a compromised skin barrier.

    “One of the main genetic factors associated with AD is the mutation in the FLG gene, which produces function impairment leading to a compromised skin barrier.”

    From Update on the pathogenesis of atopic dermatitis. (2024) · cites this paper as [49]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 119 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

  1. [39]Gutowska-Owsiak D Schaupp AL Salimi M Taylor S Ogg GS Interleukin-22 downregulates filaggrin expression and affects expression of profilaggrin processing enzymes. Br J Dermatol 2011 165 492 8 21564072

Cited by

Sorted by citations

Authors
Agrawal, R., & Woodfolk, J. A.
Affiliations
University of Virginia Health System (US)
Corresponding author
Woodfolk, Judith A.
Venue
Current Allergy and Asthma Reports
Published
2014-03-16
Volume
14
Issue
5
Pages
433-433
ISSN
  • 1529-7322 (ISSN-L)
  • 1534-6315
OpenAlex
W2070316318
Cited by
201
References
119
Citations by year
2026: 7 · 2025: 17 · 2024: 29 · 2023: 13 · 2022: 18 · 2021: 31 · 2020: 22 · 2019: 14 · 2018: 15 · 2017: 16 · 2016: 6 · 2015: 8 · 2014: 3 · 2013: 1
FWCI
12.06
Type
journal article
Language
en
Open access
Locations
  • Current Allergy and Asthma Reports (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institute of Allergy and Infectious Diseases (R01AI052196)
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR059058)
Topics
  • Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
  • Health Sciences › Medicine › Dermatology › Contact Dermatitis and Allergies
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advancements in Transdermal Drug Delivery
Keywords
atopic dermatitis, skin barrier, filaggrin, type 2 inflammation, innate immunity, antimicrobial peptides, proteolytic enzymes, skin barrier dysfunction, atopy, host-environment interactions
MeSH terms
Filaggrin Proteins, Animals, Dermatitis, Atopic, Humans, Lipid Bilayers, Peptide Hydrolases, Protease Inhibitors, Skin, Tight Junctions

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review